Literature DB >> 23320511

Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor.

Sachiyo Nishida1, Yoshihiko Hirohashi, Toshihiko Torigoe, Ryuta Inoue, Hiroshi Kitamura, Toshiaki Tanaka, Akari Takahashi, Hiroko Asanuma, Naoya Masumori, Taiji Tsukamoto, Noriyuki Sato.   

Abstract

Prostate cancer cells include a small population of cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) that have roles in initiation and progression of the cancer. Recently, we isolated prostate CSCs/CICs as aldehyde dehydrogenase 1-highh (ALDH1(high) ) cells using the ALDEFLUOR assay; however, the molecular mechanisms of prostate CSCs/CICs are still elusive. Prostate CSCs/CICs were isolated as ALDH1(high) cells using the ALDEFLUOR assay, and the gene expression profiles were analyzed using a cDNA microarray and RT-PCR. We found that prostate CSCs/CICs expressed higher levels of growth factors including hepatocyte growth factor (HGF). Hepatocyte growth factor protein expression was confirmed by enzyme linked immunosorbent assay and Western blotting. On the other hand, c-MET HGF receptor was expressed in both CSCs/CICs and non-CSCs/CICs at similar levels. Hepatocyte growth factor and the supernatant of myofibloblasts derived from the prostate augmented prostasphere formation in vitro, and prostasphere formation was inhibited by an anti-HGF antibody. Furthermore, c-MET gene knockdown by siRNA inhibited the prostasphere-forming ability in vitro and tumor-initiating ability in vivo. Taken together, the results indicate that HGF secreted by prostate CSCs/CICs and prostate myofibroblasts has a role in the maintenance of prostate CSCs/CICs in an autocrine and paracrine fashion.
© 2013 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23320511     DOI: 10.1111/cas.12104

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  18 in total

Review 1.  Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2019-07-30

2.  Expression of human kallikrein 1-related peptidase 4 (KLK4) and MET phosphorylation in prostate cancer tissue: immunohistochemical analysis.

Authors:  Shoichiro Mukai; Kenji Yorita; Koji Yamasaki; Takahiro Nagai; Toyoharu Kamibeppu; Satoru Sugie; Kazutaka Kida; Chie Onizuka; Hiromasa Tsukino; Toshio Kamimura; Toshiyuki Kamoto; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2015-04-11       Impact factor: 4.174

3.  Cripto-1 expression and its prognostic value in human bladder cancer patients.

Authors:  Bingbing Wei; Wei Jin; Jun Ruan; Zhuoqun Xu; You Zhou; Jiabei Liang; Huan Cheng; Ke Jin; Xing Huang; Peng Lu; Qiang Hu
Journal:  Tumour Biol       Date:  2014-10-19

Review 4.  Role of prostate cancer stem-like cells in the development of antiandrogen resistance.

Authors:  Prem Prakash Kushwaha; Shiv Verma; Shashank Kumar; Sanjay Gupta
Journal:  Cancer Drug Resist       Date:  2022-06-01

5.  Susceptibility of pancreatic cancer stem cells to reprogramming.

Authors:  Kozo Noguchi; Hidetoshi Eguchi; Masamitsu Konno; Koichi Kawamoto; Naohiro Nishida; Jun Koseki; Hiroshi Wada; Shigeru Marubashi; Hiroaki Nagano; Yuichiro Doki; Masaki Mori; Hideshi Ishii
Journal:  Cancer Sci       Date:  2015-08-22       Impact factor: 6.716

Review 6.  Roles of c-Met and RON kinases in tumor progression and their potential as therapeutic targets.

Authors:  Katherine Chang; Anand Karnad; Shujie Zhao; James W Freeman
Journal:  Oncotarget       Date:  2015-02-28

7.  Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis.

Authors:  J Yan; J De Melo; J-C Cutz; T Aziz; D Tang
Journal:  Br J Cancer       Date:  2014-04-24       Impact factor: 7.640

Review 8.  Met in urological cancers.

Authors:  Yasuyoshi Miyata; Akihiro Asai; Kensuke Mitsunari; Tomohiro Matsuo; Kojiro Ohba; Yasushi Mochizuki; Hideki Sakai
Journal:  Cancers (Basel)       Date:  2014-12-16       Impact factor: 6.639

9.  From AR to c-Met: androgen deprivation leads to a signaling pathway switch in prostate cancer cells.

Authors:  Tiancheng Liu; Desiree E Mendes; Clifford E Berkman
Journal:  Int J Oncol       Date:  2013-07-18       Impact factor: 5.650

10.  Prolonged androgen deprivation leads to overexpression of calpain 2: implications for prostate cancer progression.

Authors:  Tiancheng Liu; Desiree E Mendes; Clifford E Berkman
Journal:  Int J Oncol       Date:  2013-11-29       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.